- Home
- BIOX vs NSPR Comparison
BIOX vs NSPR Comparison
Compare BIOX & NSPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BIOX
- NSPR
- Stock Information
- Founded
- BIOX 2001
- NSPR 2005
- Country
- BIOX Argentina
- NSPR United States
- Employees
- BIOX N/A
- NSPR N/A
- Industry
- BIOX Agricultural Chemicals
- NSPR Medical/Dental Instruments
- Sector
- BIOX Industrials
- NSPR Health Care
- Exchange
- BIOX Nasdaq
- NSPR Nasdaq
- Market Cap
- BIOX 85.0M
- NSPR 99.7M
- IPO Year
- BIOX N/A
- NSPR N/A
- Fundamental
- Price
- BIOX $1.66
- NSPR $2.11
- Analyst Decision
- BIOX Buy
- NSPR Strong Buy
- Analyst Count
- BIOX 3
- NSPR 2
- Target Price
- BIOX $4.42
- NSPR $4.50
- AVG Volume (30 Days)
- BIOX 934.4K
- NSPR 165.8K
- Earning Date
- BIOX 11-12-2025
- NSPR 11-04-2025
- Dividend Yield
- BIOX N/A
- NSPR N/A
- EPS Growth
- BIOX N/A
- NSPR N/A
- EPS
- BIOX N/A
- NSPR N/A
- Revenue
- BIOX $318,000,000.00
- NSPR $7,779,000.00
- Revenue This Year
- BIOX $6.77
- NSPR $7.48
- Revenue Next Year
- BIOX $21.39
- NSPR $104.39
- P/E Ratio
- BIOX N/A
- NSPR N/A
- Revenue Growth
- BIOX N/A
- NSPR 14.04
- 52 Week Low
- BIOX $1.20
- NSPR $1.59
- 52 Week High
- BIOX $7.44
- NSPR $3.80
- Technical
- Relative Strength Index (RSI)
- BIOX 45.39
- NSPR 50.03
- Support Level
- BIOX $1.64
- NSPR $2.05
- Resistance Level
- BIOX $2.03
- NSPR $1.90
- Average True Range (ATR)
- BIOX 0.19
- NSPR 0.21
- MACD
- BIOX -0.01
- NSPR -0.01
- Stochastic Oscillator
- BIOX 11.46
- NSPR 64.63
About BIOX Bioceres Crop Solutions Corp.
Bioceres Crop Solutions Corp is a fully integrated provider of crop productivity solutions, including seeds, seed traits, seed treatments, biologicals, high-value adjuvants, and fertilizers. The company has developed a multi-discipline and multi-product platform capable of providing solutions throughout the entire crop cycle, from pre-planting to transportation and storage. Some of the products offered by the company include fertilizers, inoculants, adjuvants, crop protection solutions, and seeds among others. Its operating segments are crop protection, which derives key revenue, seed and integrated products, and crop nutrition. Geographically, the majority of the company's revenue is generated from Argentina and the rest from Brazil, North America, Latin America, and other regions.
About NSPR InspireMD Inc.
InspireMD Inc is a United States based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System (MGuard Prime EPS). It generates the majority of the revenue from the sales of CGuard EPS which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The group operates in Italy, Germany, Russia and other countries.